Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117935 · ClinicalTrials.gov registry record · NA
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT01117935 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 55 participants.
The verdict
NCT01117935, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Specialized radiation therapy, such as intensity-modulated radiation therapy, that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This clinical trial studies intensity-modulated external beam radiation therapy in treating patients with prostate cancer.
Interventions
- RADIATION intensity modulated external beam radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2010-05-30 |
| Est. Completion | 2019-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117935
The ClinicalTrials.gov registry entry for NCT01117935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intensity modulated external beam radiation therapy is the first listed.
NCT01117935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01117935 about?
NCT01117935 is a clinical study titled "Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Specialized radiation therapy, such as intensity-modulated radiation therapy, that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal ...
What is the current status of trial NCT01117935?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2010-05-30. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT01117935?
The interventions under investigation include: intensity modulated external beam radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01117935?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.